June 2016 | Oxford Biodynamics

OBD announced that it has expanded its collaboration with a US global biotechnology company to develop an EpiSwitch^TM signature for Alzheimer’s disease patient selection.

by Aroul Ramadass

The Atlantic publishes "Genes Are Overrated". This article points to higher order genome organisation.

Genes Are Overrated. Higher order genome conformation studied by EpiSwitch™ technology are growing trends in understanding genetics and genomics.

by Aroul Ramadass

OBD organised a press conference to announce its Diabetes epigenetics study.

Press release for Malaysian Diabetes biomarker discovery programme

by Aroul Ramadass